Both in Biotechnology
TScan Therapeutics vs Dyadic International
Over the past year TCRX returned −81.3% and DYAI returned −65.1%; their daily moves had a correlation of 0.11.
TCRX −81.3% DYAI −65.1%Growth of $1, one year, split-adjusted
| Metric | TCRX | DYAI |
|---|---|---|
| Price | $0.2100 | $0.3667 |
| Market cap | $14.2M | $14.7M |
| Today | +11.11% | +1.86% |
| 1 month | −23.7% | −19.1% |
| 6 months | −83.2% | −51.8% |
| Year to date | −79.0% | −61.0% |
| 1 year | −83.1% | −66.0% |
| Revenue growth (YoY) | −65.8% | −0.6% |
| Gross margin | 100.0% | −2.4% |
| Net margin | −2888.6% | −221.0% |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | 3.9× |
| Net cash | $67.4M | -$1.9M |
| Dividend yield | — | — |
| Volatility (60d) | 143.0% | 76.8% |
| Short % of float | 4.1% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).